newsfilter
← Latest News
PR Newswire·

YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024

YS

YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing,...